|
Volumn 12, Issue 5, 2000, Pages 276-277
|
Strategies to reduce deaths from breast cancer following mantle irradiation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTHRACYCLINE;
ANTHRACYCLINE DERIVATIVE;
ANTINEOPLASTIC AGENT;
HORMONE;
ADOLESCENT;
ADULT;
AXILLARY LYMPH NODE;
BREAST CANCER;
CANCER EPIDEMIOLOGY;
CANCER HORMONE THERAPY;
CANCER MORTALITY;
CANCER PREVENTION;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER RISK;
CANCER SCREENING;
CANCER SURVIVAL;
CANCER THERAPY;
CHILD;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
EDITORIAL;
FEMALE;
FOLLOW UP;
HODGKIN DISEASE;
HUMAN;
MAJOR CLINICAL STUDY;
MAMMOGRAPHY;
MANTLE FIELD RADIOTHERAPY;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RADIATION DOSE;
RADIATION EXPOSURE;
RADIATION INJURY;
RANDOMIZED CONTROLLED TRIAL;
RECURRENCE RISK;
RISK ASSESSMENT;
|
EID: 0033677298
PISSN: 09366555
EISSN: None
Source Type: Journal
DOI: 10.1053/clon.2000.9173 Document Type: Editorial |
Times cited : (4)
|
References (9)
|